Literature DB >> 22507049

Abnormal epidermal barrier in the pathogenesis of contact dermatitis.

Ehrhardt Proksch1, Jochen Brasch.   

Abstract

A crucial role of the epidermal permeability barrier is obvious in contact dermatitis. An intact skin barrier prevents the penetration of harmful substances into the skin. Irritants and allergens that stay on the skin surface and come into contact with the stratum corneum only do not harm the skin. After disruption of the skin barrier, however, irritants may penetrate into the living epidermal layers, injure the keratinocyte membrane, and release cytokines, which leads to inflammation and to irritant contact dermatitis. The skin barrier is often disrupted by chronic exposure to water plus detergents, solvents, or other irritants. A disrupted barrier in irritant contact dermatitis also allows for the penetration of allergens. Allergens may come into contact with Langerhans and T cells, induce immunological reactions, and cause inflammation, which results in allergic contact dermatitis. Treatments in contact dermatitis should restore the skin barrier to prevent relapse of the disease. Topical corticosteroids, most often used in treating contact dermatitis, reduce immunological reactions and inflammation but do not lead to a complete barrier repair. Skin barrier repair is more complete after treatment with calcineurin inhibitors and bland lipid-based emollient; therefore, these preparations should be preferred for long-term treatment of contact dermatitis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507049     DOI: 10.1016/j.clindermatol.2011.08.019

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  20 in total

Review 1.  The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.

Authors:  Joshua L Owen; Paras P Vakharia; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

2.  [Aged-related principles of topical therapy].

Authors:  E Proksch
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

Review 3.  Activated protein C: A regulator of human skin epidermal keratinocyte function.

Authors:  Kelly McKelvey; Christopher John Jackson; Meilang Xue
Journal:  World J Biol Chem       Date:  2014-05-26

Review 4.  [Epidermal barrier disorders in dermatoses].

Authors:  E Proksch; D Dähnhardt; R Fölster-Holst
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

Review 5.  The link between cutaneous inflammation and cognitive impairment.

Authors:  S Wen; P M Elias; J S Wakefield; T M Mauro; M-Q Man
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-07-02       Impact factor: 9.228

Review 6.  Natural (Mineral, Vegetable, Coconut, Essential) Oils and Contact Dermatitis.

Authors:  Vermén M Verallo-Rowell; Stephanie S Katalbas; Julia P Pangasinan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

7.  AHAPS-functionalized silica nanoparticles do not modulate allergic contact dermatitis in mice.

Authors:  Anja Ostrowski; Daniel Nordmeyer; Lars Mundhenk; Joachim W Fluhr; Jürgen Lademann; Christina Graf; Eckart Rühl; Achim D Gruber
Journal:  Nanoscale Res Lett       Date:  2014-09-24       Impact factor: 4.703

Review 8.  New era of biologic therapeutics in atopic dermatitis.

Authors:  Emma Guttman-Yassky; Nikhil Dhingra; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2013-01-16       Impact factor: 4.388

Review 9.  Strategies to Develop a Suitable Formulation for Inflammatory Skin Disease Treatment.

Authors:  Jiun-Wen Guo; Shiou-Hwa Jee
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling.

Authors:  Hung-Lin Chen; Po-Cheng Chiang; Chia-Hui Lo; Yuan-Hsin Lo; Daniel K Hsu; Huan-Yuan Chen; Fu-Tong Liu
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.